Skip to search.
 TSX Up 0.23% TSX Ventures Up 0.62%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
20.27 Down 1.38(6.35%) 11:19AM EST - Nasdaq Real Time Price
Prev Close:21.65
Open:21.20
Bid:20.45 x 200
Ask:20.50 x 400
1y Target Est:35.25
Beta:1.29327
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:20.00 - 21.50
52wk Range:16.40 - 43.63
Volume:145,017
Avg Vol (3m):668,875
Market Cap:934.97M
P/E (ttm):N/A
EPS (ttm):-0.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORDown 6.35%934.97M
BIIBDown 3.49%61.14B

Key Statistics

Forward P/E (1 yr):27.27
P/S (ttm):1.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.20
Quarterly EPS Est (Dec-16) :0.10
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):3.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback